AYVAKIT

avapritinib · Blueprint Medicines Corporation

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for AYVAKIT, covering 2020-01-09 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations